Dental Practice Funding More News: Trevena opioid painkiller fails to win FDA approval, shares plunge

[ad_1]

Trevena Inc shares plunged 45 percent on Friday after the U.S. Food and Drug Administration declined to approve its opioid injection for managing acute pain, citing inadequate safety data.

[ad_2]

Source link